Clinical trial

Effects of Inhaled Corticosteroids in the Systemic Inflammation Induced by Exercise in Patients With COPD

NCT02209974

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Fluticasone Normalized identity: fluticasoneView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Inhaled Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effects of Inhaled Corticosteroids in the Systemic Inflammation Induced by Exercise in Patients With COPD

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-02-01

PhasePHASE4

Conditions

Chronic Obstructive Pulmonary Diseaseverified · MONDO: chronic obstructive pulmonary disease

Interventions

FluticasoneDRUG · verified · RxNorm: fluticasone

Inhaled PlaceboDRUG

Sponsors & collaborators

Hospital Son Llatzerlead sponsor

Sociedad Española de Neumología y Cirugía Torácicacollaborator

Hospital Son Espasescollaborator

Spanish Research Center for Respiratory Diseasescollaborator

Hospital Clinic of Barcelonacollaborator

Fundació d'investigació Sanitària de les Illes Balearscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02209974 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.